Prophage Gifsy-1 Induction in Salmonella enterica Serovar Typhimurium Reduces Persister Cell Formation after Ciprofloxacin Exposure.


Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
17 08 2023
Historique:
medline: 21 8 2023
pubmed: 12 6 2023
entrez: 12 6 2023
Statut: ppublish

Résumé

Persister cells are drug-tolerant bacteria capable of surviving antibiotic treatment despite the absence of heritable resistance mechanisms. It is generally thought that persister cells survive antibiotic exposure through the implementation of stress responses and/or energy-sparing strategies. Exposure to DNA gyrase-targeting antibiotics could be particularly detrimental for bacteria that carry prophages integrated in their genomes. Gyrase inhibitors are known to induce prophages to switch from their dormant lysogenic state into the lytic cycle, causing the lysis of their bacterial host. However, the influence of resident prophages on the formation of persister cells has only been recently appreciated. Here, we evaluated the effect of endogenous prophage carriage on the generation of bacterial persistence during Salmonella enterica serovar Typhimurium exposure to both gyrase-targeting antibiotics and other classes of bactericidal antibiotics. Results from the analysis of strain variants harboring different prophage combinations revealed that prophages play a major role in limiting the formation of persister cells during exposure to DNA-damaging antibiotics. In particular, we present evidence that prophage Gifsy-1 (and its encoded lysis proteins) are major factors limiting persister cell formation upon ciprofloxacin exposure. Resident prophages also appear to have a significant impact on the initial drug susceptibility, resulting in an alteration of the characteristic biphasic killing curve of persister cells into a triphasic curve. In contrast, a prophage-free derivative of

Identifiants

pubmed: 37306609
doi: 10.1128/spectrum.01874-23
pmc: PMC10433948
doi:

Substances chimiques

Ciprofloxacin 5E8K9I0O4U
Anti-Bacterial Agents 0
DNA Gyrase EC 5.99.1.3
beta-Lactams 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0187423

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Mol Cell. 2016 Apr 21;62(2):284-294
pubmed: 27105118
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5497-502
pubmed: 25870259
Antimicrob Agents Chemother. 2018 Feb 23;62(3):
pubmed: 29229642
PLoS Biol. 2010 Feb 23;8(2):e1000317
pubmed: 20186264
Appl Environ Microbiol. 2018 Oct 30;84(22):
pubmed: 30217844
Virology. 2006 Aug 1;351(2):360-7
pubmed: 16713610
PLoS One. 2010 Jun 14;5(6):e11106
pubmed: 20559442
Antimicrob Agents Chemother. 1994 Jun;38(6):1284-91
pubmed: 8092826
J Nucleic Acids. 2010 Dec 16;2010:592980
pubmed: 21209706
Virology. 1972 Dec;50(3):883-98
pubmed: 4565618
J Bacteriol. 2007 Sep;189(17):6303-11
pubmed: 17601790
J Bacteriol. 2000 Aug;182(16):4406-13
pubmed: 10913072
J Med Microbiol. 2011 Jun;60(Pt 6):699-709
pubmed: 21459912
Vet Microbiol. 2017 Oct;210:116-123
pubmed: 29103680
Nat Microbiol. 2016 Apr 18;1:16051
pubmed: 27572649
Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0234421
pubmed: 35658490
Cold Spring Harb Symp Quant Biol. 1968;33:721-7
pubmed: 5254581
Gut Microbes. 2020 Nov 9;12(1):1813533
pubmed: 32985336
Clin Microbiol Rev. 2019 Jan 16;32(2):
pubmed: 30651225
Genetics. 2013 Dec;195(4):1265-76
pubmed: 24077306
Annu Rev Microbiol. 2000;54:799-825
pubmed: 11018145
Science. 2004 Sep 10;305(5690):1622-5
pubmed: 15308767
J Bacteriol. 2005 Dec;187(23):7901-11
pubmed: 16291663
mBio. 2017 Dec 12;8(6):
pubmed: 29233898
Antimicrob Agents Chemother. 2012 Sep;56(9):4922-6
pubmed: 22777047
Annu Rev Microbiol. 2010;64:357-72
pubmed: 20528688
J Antimicrob Chemother. 1987 Nov;20(5):631-8
pubmed: 3323160
Pharmaceuticals (Basel). 2015 Nov 17;8(4):778-92
pubmed: 26593926
Mol Microbiol. 2001 Jan;39(2):260-71
pubmed: 11136448
mBio. 2017 Feb 7;8(1):
pubmed: 28174313
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
pubmed: 10829079
Mol Gen Genet. 1995 Jan 20;246(2):174-9
pubmed: 7862088
J Bacteriol. 2010 Jan;192(2):560-7
pubmed: 19897643
Gene. 1995 May 26;158(1):9-14
pubmed: 7789817
PLoS Genet. 2011 Jun;7(6):e1002149
pubmed: 21731505
Mol Microbiol. 1997 Jul;25(1):161-73
pubmed: 11902718
Antimicrob Agents Chemother. 1996 Jun;40(6):1561-3
pubmed: 8726041
Antibiotics (Basel). 2021 Nov 26;10(12):
pubmed: 34943668
Antimicrob Agents Chemother. 1975 Sep;8(3):251-61
pubmed: 1101818
PLoS One. 2013;8(1):e54737
pubmed: 23358116
J Bacteriol. 2003 Nov;185(21):6481-5
pubmed: 14563886
mSystems. 2022 Aug 30;7(4):e0032622
pubmed: 35880895
PLoS One. 2007 Aug 29;2(8):e799
pubmed: 17726529
Nat Commun. 2010;1:147
pubmed: 21266997
J Mol Biol. 1968 Feb 14;31(3):487-505
pubmed: 5637199
Front Microbiol. 2020 Aug 04;11:1785
pubmed: 32849403
Antimicrob Agents Chemother. 2001 Mar;45(3):649-59
pubmed: 11181338
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13206-11
pubmed: 21788497

Auteurs

Sebastian Braetz (S)

Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Veterinary Centre for Resistance Research (TZR), Freie Universität Berlin, Berlin, Germany.

Peter Schwerk (P)

Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Veterinary Centre for Resistance Research (TZR), Freie Universität Berlin, Berlin, Germany.

Nara Figueroa-Bossi (N)

Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France.

Karsten Tedin (K)

Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Veterinary Centre for Resistance Research (TZR), Freie Universität Berlin, Berlin, Germany.

Marcus Fulde (M)

Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Veterinary Centre for Resistance Research (TZR), Freie Universität Berlin, Berlin, Germany.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Humans China Cerebral Hemorrhage Patient Care Bundles Length of Stay

Classifications MeSH